Tratamiento anticoagulante oral en pacientes sometidos a remplazo valvular en un hospital general de Antofagasta, Chile

Arce, Carlos Félix; Mir, Ian; Maqueira, Piero; Solari, Bruno; Labbé, Javier

doi:10.4067/s0718-85602016000200008

Cited by 1 publication

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Of the patients, 77.4% were women, 90% had a mechanical prosthesis, and 60% had an INR in the indicated range. 16 A recently published study using the Global Anticoagulant Registry in the Field (GARFIELD-AF) registry in Chile included 971 patients with AF, recruited both in public hospitals (85%) and private clinics (15%). The 70% of patients who were treated with VKA had a median TTR of 40%.…”

Section: Introductionmentioning

confidence: 99%

Anticoagulation Management With Coumarinic Drugs in Chilean Patients

Nieto

Suárez

Roco

et al. 2019

Clin Appl Thromb Hemost

View full text Add to dashboard Cite

Warfarin and acenocoumarol are used in various cardiovascular disorders to improve the prognosis of patients with thromboembolic disease. However, there is a lack of substantial efficacy and safety data on antithrombotic prophylaxis in several countries, particularly in Latin America. The aim of this study was to provide information about the efficacy of anticoagulants in Chilean patients. Data were collected from databases of the Western Metropolitan Health Service, Santiago, Chile. We identified 6280 records of patients receiving anticoagulant treatment. The three most common diagnoses were rhythm disorder (43.7%), venous thrombosis (22%), and valvular prosthesis (10.7%). The majority of patients (98.5%) received acenocoumarol while 1.5% of patients received warfarin, at weekly therapeutic doses of 13.6 mg and 30.4 mg, respectively. For total diagnoses, the median time in the therapeutic range was 50%. However, better results, 66.7%, were observed when a telemedicine strategy was used only in Santiago Province. Our findings emphasize that in Chile, where the number of patients receiving anticoagulant treatment increases every year, telemedicine, by committed teams, improves the use of oral anticoagulants and is able to increase quality indicators of anticoagulant treatment care.

show abstract

Section: Introductionmentioning

confidence: 99%